Latest Insider Transactions at Quoin Pharmaceuticals, Ltd. (QNRX)
This section provides a real-time view of insider transactions for Quoin Pharmaceuticals, Ltd. (QNRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Quoin Pharmaceuticals, Ltd. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Quoin Pharmaceuticals, Ltd.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 10
2024
|
Gordon Dunn Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+30.2%
|
$0
$0.81 P/Share
|
|
Sep 09
2024
|
Gordon Dunn Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
8,856
+42.09%
|
$0
$0.79 P/Share
|
|
Sep 04
2024
|
Denise P. Carter Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
31,813
+29.8%
|
$0
$0.78 P/Share
|
|
Sep 04
2024
|
Michael Myers Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
37,094
+28.2%
|
$0
$0.74 P/Share
|
|
Sep 03
2024
|
Denise P. Carter Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
5,922
+17.59%
|
$0
$0.65 P/Share
|
|
Sep 03
2024
|
Michael Myers Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
800
+7.3%
|
$0
$0.62 P/Share
|
|
Jun 07
2024
|
Dennis Langer Director |
SELL
Open market or private sale
|
Direct |
297
-84.86%
|
$0
$0.73 P/Share
|